BrightSpring Health Services, Inc. Common Stock (BTSG) Stock
Key stats
- Market cap
- $14.45B
- Price / Earnings ratio
- 35.2x
- EPS (TTM)
- $2.00
- Volume
- Loading
- 52-week high
- $73.75
- 52-week low
- $30.64
Source: third-party data provider, as of November 13, 2026
Compare with BTSG
Recent news

Why BrightSpring Health Services, Inc. (BTSG) is a Top Value Stock for the Long-Term
Why BrightSpring Health Services, Inc. (BTSG) is a Top Value Stock for the Long-Term
BTSG

BrightSpring Q3 Earnings Beat on Specialty Growth, '26 View Raised
BrightSpring Q3 Earnings Beat on Specialty Growth, '26 View Raised
BTSG

BTSG Q3 Earnings Call Highlights Raised Guidance and 2027 Growth
BTSG Q3 Earnings Call Highlights Raised Guidance and 2027 Growth
BTSG

BrightSpring Health Services Q3 Earnings Call Highlights
BrightSpring Health Services Q3 Earnings Call Highlights
BTSG
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 69.42
- MACD 12/26/9
- 2.72
- EMA 9 of MACD
- 1.79
- MACD histogram
- 0.93
- SMA 50
- $61.51
- Price above SMA 50
- EMA 50
- $63.18
- Price above EMA 50
- SMA 200
- $55.87
- Price above SMA 200
- EMA 200
- $54.49
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 5 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

Why BrightSpring Health Services, Inc. (BTSG) is a Top Value Stock for the Long-Term
Why BrightSpring Health Services, Inc. (BTSG) is a Top Value Stock for the Long-Term
BTSG

BrightSpring Q3 Earnings Beat on Specialty Growth, '26 View Raised
BrightSpring Q3 Earnings Beat on Specialty Growth, '26 View Raised
BTSG

BTSG Q3 Earnings Call Highlights Raised Guidance and 2027 Growth
BTSG Q3 Earnings Call Highlights Raised Guidance and 2027 Growth
BTSG

BrightSpring Health Services Q3 Earnings Call Highlights
BrightSpring Health Services Q3 Earnings Call Highlights
BTSG

Here's What Key Metrics Tell Us About BrightSpring Health Services, Inc. (BTSG) Q3 Earnings
Here's What Key Metrics Tell Us About BrightSpring Health Services, Inc. (BTSG) Q3 Earnings
BTSG

BrightSpring Health Services, Inc. (BTSG) Q3 Earnings and Revenues Surpass Estimates
BrightSpring Health Services, Inc. (BTSG) Q3 Earnings and Revenues Surpass Estimates
BTSG

BTSG Ahead of Q3 Earnings: Can Growth Offset Ongoing IRA Risks?
BTSG Ahead of Q3 Earnings: Can Growth Offset Ongoing IRA Risks?
BTSG

BTSG Stock Climbs 67.3% YTD: What's Driving the Rally in 2026?
BTSG Stock Climbs 67.3% YTD: What's Driving the Rally in 2026?
BTSG

BTSG Deploys AI Across Operations: Will It Improve Margins?
BTSG Deploys AI Across Operations: Will It Improve Margins?
BTSG

BrightSpring Health Services, Inc. (BTSG) is a Top-Ranked Value Stock: Should You Buy?
BrightSpring Health Services, Inc. (BTSG) is a Top-Ranked Value Stock: Should You Buy?
BTSG
News tone: automated (AI) classification of the article's content, not a price prediction.
About BrightSpring Health Services, Inc. Common Stock
No description available.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Jon B. Rousseau | Chairman, President & CEO | 1974 |
| Ms. Jennifer A. Phipps | CFO, Executive VP & Corporate Secretary | 1981 |
| Ms. Lisa Nalley | Chief of Staff & Senior VP of Human Resources | 1973 |
| Ms. Jennifer Yowler | Senior VP of Sales & Account Management - PharMerica | 1977 |
| Mr. Scott Greenwell Pharm.D. | Executive VP & President of PharMerica | — |
| Mr. Charles H. Wardrip | Chief Information Officer | — |
| Mr. David J. Deuchler C.F.A. | Senior VP of Strategic Finance & IR and Executive Director of BrightSpring Health Foundation | — |
| Ms. Rachael Kurzer Givens | Chief Compliance Officer | — |
| Mr. Jeffrey A, Hopper Esq. | Legal Counsel | — |
| Mr. Mike McMaude | Consultant | 1968 |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 69.42
- MACD 12/26/9
- 2.72
- EMA 9 of MACD
- 1.79
- MACD histogram
- 0.93
- SMA 50
- $61.51
- Price above SMA 50
- EMA 50
- $63.18
- Price above EMA 50
- SMA 200
- $55.87
- Price above SMA 200
- EMA 200
- $54.49
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
5 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $82.00
- Average
- $86.80
- High
- $92.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | +0.2 | -20.5 | +21.5 | -2.7 | +5.5 | -1.4 | +13.0 | +2.6 | +17.3 | +1.3 | +11.9 | -10.7 |
| 2025 | +36.2 | -18.7 | -2.3 | -2.3 | +33.0 | -1.4 | -7.3 | +20.6 | +23.8 | +10.8 | +8.0 | +4.3 |
| 2026 | +2.3 | +2.3 | +2.5 | +14.1 | +17.3 | +16.3 | -14.5 | -3.4 | -4.1 | +16.8 | +9.4 |



